Centene Corp. (0HVB)
London Stock Exchange · UK · prices in USD · close of 27 Oct 2026
Key indicators
| Last close | USD 69.24 |
|---|---|
| 52-week range | 30.91 – 72.41 |
| Return, 1 month / 3 months | +11.9% / +7.6% |
| Return, 1 year / 3 years | +108.4% / +2.4% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 44.3% |
| Worst drawdown (1 year) | -32.9% |
| Average daily value traded | 0.32M USD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Centene Corporation is a managed care organisation that provides health insurance and related services, mainly through government-sponsored healthcare programmes. Its health plans serve members covered by Medicaid, Medicare and individual insurance marketplaces, and it also offers specialty services such as pharmacy benefits and behavioural health. The company is based in St. Louis, Missouri, and works with state agencies, providers and members across the United States.
On this site Centene Corp. appears as a stock on the London Stock Exchange (UK), code 0HVB, with prices in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Centene Corp. (0HVB) trades on the London Stock Exchange in UK. It last closed at USD 69.24 on 27 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 772 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 108.4% and over the last three months it rose 7.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 90 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 25.4% | ||
| From 52-week high | -3.6% | ||
| Momentum | 88 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 7.6% | ||
| 6-month return | 60.0% | ||
| 12-month return, skipping the last month | 86.2% | ||
| Stability (higher is calmer) | 39 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 44.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.9% | ||
| Liquidity | 42 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.32M USD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.7% |
|---|---|
| 1 month | +11.9% |
| 3 months | +7.6% |
| 6 months | +60.0% |
| 1 year | +108.4% |
| 3 years | +2.4% |
| 5 years | −3.7% |
Signals
| 50-day / 200-day average | 66.02 / 55.22 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.29 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.